does the va cover glp-1 drugs Racial discrepancies found in SGLT2, drug prescriptions in health system Weight loss drugs coverage |
Description
"DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study"
Several evidence-based alternatives to Ozempic exist for weight management and metabolic health, including other GLP-1 receptor agonists, dual-action compounds, and personalized dosing protocols
More research is warranted in order to further consolidate these findings across different type 2 diabetes mellitus (T2DM) subpopulations, and adequately powered studies with a longer follow-up that would allow the exploration of microvascular and macrovascular complications are needed
[DOI] [PubMed] [Google Scholar] 61.Cui X, Zhu Y, Zeng L, Zhang M, Uddin A, Gillespie TW, McCullough LE, Zhao S, Torres MA, Wan Y
Microbiome-based GLP-1 modulation
February 6, 2009
